Adult Hodgkin Lymphoma — Trials

Adult Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 5
Ph III recruiting: 2
Growth YoY: —
Industry share: 22%
Top sponsor: AIDS Malignancy Consortium
Termination share: 26%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04938232	Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL	active not recruiting	Phase 2	13	Dana-Farber Cancer InstituteOTHER	1	Sep 16, 2026	clinicaltrials
NCT07021989	ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma	recruiting	Phase 2	38	Michael Spinner, MDOTHER	1	Aug 20, 2026	clinicaltrials
NCT05346809